Avenue Therapeutics News

Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.0%)

Apr 17 16:11 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Apr 17 16:10 ET

Avenue Therapeutics | 8-K: Current report

Mar 29 14:43 ET

Avenue Therapeutics | DEF 14C: Definitive information statements

Mar 18 17:01 ET

Avenue Therapeutics | 10-K: Annual report

Mar 18 16:23 ET

Avenue Therapeutics | 8-K: Current report

Mar 18 16:16 ET

Avenue Therapeutics | 8-K: Current report

Mar 15 07:20 ET

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Mar 8 16:38 ET

Avenue Therapeutics | 8-K: Current report

Mar 8 16:19 ET

Avenue Therapeutics | 8-K: Current report

Feb 23 16:25 ET

Avenue Therapeutics | 424B3: Prospectus

Feb 2 11:46 ET

Avenue Therapeutics | EFFECT: Others

Feb 2 06:05 ET

Avenue Therapeutics | CORRESP: CORRESP

Jan 30 11:45 ET

Avenue Therapeutics | UPLOAD: Others

Jan 29 11:45 ET

Avenue Therapeutics | DEF 14C: Definitive information statements

Jan 29 08:03 ET

Avenue Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jan 24 16:15 ET

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Jan 17 00:00 ET

Avenue Therapeutics | 8-K: Current report

Jan 12 00:00 ET

Avenue Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Jan 3 00:00 ET